JPMA To Implement Publication Of Individual Doctor Lecture Fees As Planned In 2014
This article was originally published in PharmAsia News
The Japan Pharmaceutical Manufacturers Association will continue as planned with the publication of individual doctor manuscript and lecture fees paid by pharmaceutical companies in 2014, JPMA President Isao Teshirogi announced at a Tokyo press conference.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.